DO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO

dc.contributor.author	Inel, TY; Kocaer, SB; Erez, Y; Gulle, S; Karakas, A; Avsar, AK; Uslu, S; Can, G; Sari, I; Birlik, M; Dalkilic, E; Pehlivan, Y; Akar, S; Goker, B; Cetin, GY; Haznedaroglu, S; Yavuz, S; Pirildar, T; Direskeneli, H; Akkoc, N; Onen, F
dc.date.accessioned	2023-03-02T06:38:39Z
dc.date.available	2023-03-02T06:38:39Z
dc.date.issued	JUN
dc.date.issued	2020
dc.identifier.uri	http://hdl.handle.net/20.500.12481/14270
dc.title	DO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO
dc.title.alternative	ANNALS OF THE RHEUMATIC DISEASES
dc.identifier.DOI-ID	10.1136/annrheumdis-2020-eular.1599
dc.identifier.volume	79
dc.identifier.startpage	978
dc.identifier.endpage	978
dc.identifier.issn/e-issn	0003-4967
dc.identifier.issn/e-issn	1468-2060

Files in this item

Files	Size	Format	View
There are no files associated with this item.